期刊
AUTOIMMUNITY REVIEWS
卷 13, 期 2, 页码 114-116出版社
ELSEVIER
DOI: 10.1016/j.autrev.2013.09.011
关键词
Inflammatory bowel disease; Multiple sclerosis; Th17 cells; Blood brain barrier
类别
Inflammatory bowel disease (IBD) and multiple sclerosis (MS) are autoimmune diseases with a close relationship to their disease pattern add immunologic cascade with considerable morbidity and mortality. This article provides insight of why tumor necrosis factor blockers couldn't work in multiple sclerosis and why interferon-beta doesn't work in inflammatory bowel disease. In this article, we provide a detailed review of the linkage and potential interchangeable medication between IBD and MS in addition to Natalizumab, Trichuris suis egg therapy and vitamin D. Different treatment strategies may have potential in treating both diseases in the future. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据